These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9346366)

  • 1. Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
    Feldmann M; Brennan F; Paleolog E; Taylor P; Maini RN
    Eur Cytokine Netw; 1997 Sep; 8(3):297-300. PubMed ID: 9346366
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokines in rheumatoid arthritis: is it all TNF-alpha?
    Miossec P
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):675-8. PubMed ID: 11502074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy in rheumatoid arthritis; current status].
    Breedveld FC; van de Putte LB
    Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1255-9. PubMed ID: 8700279
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
    Charles P; Elliott MJ; Davis D; Potter A; Kalden JR; Antoni C; Breedveld FC; Smolen JS; Eberl G; deWoody K; Feldmann M; Maini RN
    J Immunol; 1999 Aug; 163(3):1521-8. PubMed ID: 10415055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cytokines in the pathogenesis of rheumatoid arthritis.
    Feldmann M; Maini RN
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():3-7. PubMed ID: 10646481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
    Brennan FM; Cope AP; Katsikis P; Gibbons DL; Maini RN; Feldmann M
    Chem Immunol; 1995; 60():48-60. PubMed ID: 7857528
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy.
    Popa C; Netea MG; Barrera P; Radstake TR; van Riel PL; Kullberg BJ; Van der Meer JW
    Cytokine; 2005 Apr; 30(2):72-7. PubMed ID: 15804598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gammalinolenic acid on interleukin-1 beta and tumor necrosis factor-alpha secretion by stimulated human peripheral blood monocytes: studies in vitro and in vivo.
    DeLuca P; Rossetti RG; Alavian C; Karim P; Zurier RB
    J Investig Med; 1999 May; 47(5):246-50. PubMed ID: 10361385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor inhibitor therapy for rheumatoid arthritis.
    Naguwa SM
    Ann N Y Acad Sci; 2005 Jun; 1051():709-15. PubMed ID: 16127011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha-targeted therapy in rheumatoid arthritis.
    Wendling D; Toussirot E
    Rev Rhum Engl Ed; 1999 Apr; 66(4):187-91. PubMed ID: 10339773
    [No Abstract]   [Full Text] [Related]  

  • 12. [Double-blind trial of the effectiveness of antibodies to interferon-gamma and tumor necrosis factor-alpha in rheumatoid arthritis (preliminary results)].
    Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS
    Ter Arkh; 2001; 73(5):12-5. PubMed ID: 11517739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-blocking therapies: an alternative mode of action?
    Choo-Kang BS; Hutchison S; Nickdel MB; Bundick RV; Leishman AJ; Brewer JM; McInnes IB; Garside P
    Trends Immunol; 2005 Oct; 26(10):518-22. PubMed ID: 16087401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-cytokine therapy in inflammatory joint diseases].
    Ehrenfeld M; Langevitz P; Shoenfeld Y
    Harefuah; 1999 Aug; 137(3-4):120-4. PubMed ID: 10959300
    [No Abstract]   [Full Text] [Related]  

  • 15. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.
    Feldmann M; Maini RN
    Nat Med; 2003 Oct; 9(10):1245-50. PubMed ID: 14520364
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of tumor necrosis factor (TNF-alpha) in rheumatoid arthritis].
    Godyń-Swedzioł RM; Stańczyk J; Hilt J; Kowalski ML
    Przegl Lek; 2004; 61(2):90-3. PubMed ID: 15230148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leukocytapheresis for therapy of rheumatoid arthritis].
    Ueki Y; Eguchi K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():649-52. PubMed ID: 15799436
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrotic syndrome associated with anti-tumor necrosis factor alpha therapy in a patient with rheumatoid arthritis: comment on the article by Charles et al.
    den Broeder AA; Assmann KJ; van Riel PL; Wetzels JF
    Arthritis Rheum; 2002 Jun; 46(6):1691-3; author reply 1693. PubMed ID: 12115204
    [No Abstract]   [Full Text] [Related]  

  • 20. Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
    Sørensen LK; Havemose-Poulsen A; Bendtzen K; Holmstrup P
    J Periodontol; 2009 Feb; 80(2):282-9. PubMed ID: 19186969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.